DMGDH
Basic information
Region (hg38): 5:78997564-79236038
Links
Phenotypes
GenCC
Source:
- dimethylglycine dehydrogenase deficiency (Supportive), mode of inheritance: AR
- dimethylglycine dehydrogenase deficiency (Limited), mode of inheritance: AR
- dimethylglycine dehydrogenase deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Dimethylglycine dehydrogenase deficiency | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Musculoskeletal | 10102904 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DMGDH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 22 | ||||
missense | 44 | 55 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 7 | 1 | 8 | |||
non coding | 16 | 15 | 32 | |||
Total | 0 | 2 | 47 | 39 | 24 |
Variants in DMGDH
This is a list of pathogenic ClinVar variants found in the DMGDH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-78998074-G-A | Uncertain significance (Aug 01, 2016) | |||
5-78998117-G-A | not specified | Uncertain significance (Nov 29, 2021) | ||
5-78998138-A-G | Likely benign (Mar 01, 2022) | |||
5-78998148-T-C | not specified • DMGDH-related disorder | Benign (Jun 16, 2017) | ||
5-78998219-G-A | Likely benign (May 24, 2018) | |||
5-78998233-T-A | not specified | Uncertain significance (Nov 07, 2023) | ||
5-79005225-G-GT | Benign (Apr 16, 2019) | |||
5-79005261-C-G | not specified | Likely benign (Aug 09, 2016) | ||
5-79005262-T-G | not specified | Likely benign (Dec 15, 2016) | ||
5-79005307-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
5-79005349-C-T | Likely benign (Feb 01, 2023) | |||
5-79005397-A-G | DMGDH-related disorder | Benign (Oct 28, 2019) | ||
5-79005431-G-A | Benign (Feb 26, 2021) | |||
5-79005503-A-G | Benign (Apr 16, 2019) | |||
5-79005540-T-A | Benign (Apr 16, 2019) | |||
5-79024136-A-G | Likely benign (Mar 17, 2021) | |||
5-79024262-T-C | not specified • DMGDH-related disorder | Benign (Dec 10, 2015) | ||
5-79024308-A-C | not specified | Uncertain significance (Jun 23, 2023) | ||
5-79024325-G-A | not specified | Likely benign (Jul 01, 2024) | ||
5-79026459-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
5-79026459-G-T | not specified | Uncertain significance (Feb 22, 2023) | ||
5-79026474-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
5-79026492-C-T | Dimethylglycine dehydrogenase deficiency | Uncertain significance (Mar 05, 2018) | ||
5-79026539-A-G | not specified | Likely benign (Dec 14, 2022) | ||
5-79026598-G-A | not specified | Likely benign (Mar 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DMGDH | protein_coding | protein_coding | ENST00000255189 | 16 | 238424 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.05e-24 | 0.00276 | 125192 | 3 | 553 | 125748 | 0.00221 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.563 | 409 | 442 | 0.925 | 0.0000232 | 5598 |
Missense in Polyphen | 146 | 176.15 | 0.82885 | 2078 | ||
Synonymous | -0.838 | 174 | 160 | 1.08 | 0.00000876 | 1711 |
Loss of Function | 0.622 | 39 | 43.4 | 0.898 | 0.00000242 | 532 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00425 | 0.00425 |
Ashkenazi Jewish | 0.00169 | 0.00169 |
East Asian | 0.00207 | 0.00207 |
Finnish | 0.00120 | 0.00120 |
European (Non-Finnish) | 0.00208 | 0.00207 |
Middle Eastern | 0.00207 | 0.00207 |
South Asian | 0.00301 | 0.00301 |
Other | 0.00358 | 0.00359 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the demethylation of N,N-dimethylglycine to sarcosine. Also has activity with sarcosine in vitro. {ECO:0000269|PubMed:27486859}.;
- Disease
- DISEASE: DMGDH deficiency (DMGDHD) [MIM:605850]: Disorder characterized by fish odor, muscle fatigue with increased serum creatine kinase. Biochemically it is characterized by an increase of N,N-dimethylglycine (DMG) in serum and urine. {ECO:0000269|PubMed:11231903, ECO:0000269|PubMed:27486859}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycine, serine and threonine metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Non Ketotic Hyperglycinemia;Glycine and Serine Metabolism;sarcosine oncometabolite pathway ;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);One carbon metabolism and related pathways;Metabolism of amino acids and derivatives;Glycine Serine metabolism;Metabolism;Choline catabolism;glycine betaine degradation;superpathway of choline degradation to L-serine;Glycine, serine, alanine and threonine metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.346
- rvis_EVS
- 0.16
- rvis_percentile_EVS
- 64.92
Haploinsufficiency Scores
- pHI
- 0.0898
- hipred
- N
- hipred_score
- 0.457
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.840
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Dmgdh
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- amino-acid betaine catabolic process;choline metabolic process;electron transport chain;choline catabolic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;electron transfer activity;oxidoreductase activity;dimethylglycine dehydrogenase activity